Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force

IMPORTANCE: Multifactorial dyslipidemia, characterized by elevated total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C), is associated with dyslipidemia and markers of atherosclerosis in young adulthood. Screening for dyslipidemia in childhood could delay or reduce cardiovascular ev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2016-08, Vol.316 (6), p.634-644
Hauptverfasser: Lozano, Paula, Henrikson, Nora B, Morrison, Caitlin C, Dunn, John, Nguyen, Matt, Blasi, Paula R, Whitlock, Evelyn P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 644
container_issue 6
container_start_page 634
container_title JAMA : the journal of the American Medical Association
container_volume 316
creator Lozano, Paula
Henrikson, Nora B
Morrison, Caitlin C
Dunn, John
Nguyen, Matt
Blasi, Paula R
Whitlock, Evelyn P
description IMPORTANCE: Multifactorial dyslipidemia, characterized by elevated total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C), is associated with dyslipidemia and markers of atherosclerosis in young adulthood. Screening for dyslipidemia in childhood could delay or reduce cardiovascular events in adulthood. OBJECTIVE: To systematically review the evidence on benefits and harms of screening adolescents and children for multifactorial dyslipidemia for the US Preventive Services Task Force (USPSTF). DATA SOURCES: MEDLINE, Cochrane Central Register of Controlled Trials, and PubMed were searched for studies published between January 1, 2005, and June 2, 2015; studies included in a previous USPSTF evidence report and reference lists of relevant studies and ongoing trials were also searched. Surveillance was conducted through April 9, 2016. STUDY SELECTION: Fair- and good-quality studies in English with participants 0 to 20 years of age. DATA EXTRACTION AND SYNTHESIS: Two investigators independently reviewed abstracts and full-text articles and extracted data into evidence tables. Results were qualitatively summarized. MAIN OUTCOMES AND MEASURES: Outcomes included dyslipidemia (TC≥200 mg/dL or LDL-C≥130 mg/dL) and atherosclerosis in childhood; myocardial infarction and ischemic stroke in adulthood; diagnostic yield (number of confirmed cases per children screened); and harms of screening or treatment. Simulated diagnostic yield was calculated as initial screening yield × positive predictive value from a study with confirmatory testing. RESULTS: Screening of children for multifactorial dyslipidemia has not been evaluated in randomized clinical trials. Based on 1 observational study (n = 6500) and nationally representative prevalence estimates, the simulated diagnostic yield of screening for elevated TC varies between 4.8% and 12.3% (higher in obese children [12.3%] and at the ages when TC naturally peaks—7.2% at age 9-11 years and 7.2% at age 16-19 years). One good-quality randomized clinical trial (n = 663) found a modest effect of intensive dietary counseling for a low-fat, low-cholesterol diet on lipid levels at 1 year in children aged 8 to 10 years with mild to moderate dyslipidemia; mean between-group difference in TC change from baseline was −6.1 mg/dL (95% CI, −9.1 to −3.2 mg/dL; P 
doi_str_mv 10.1001/jama.2016.6423
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1812887291</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2542640</ama_id><sourcerecordid>4155808381</sourcerecordid><originalsourceid>FETCH-LOGICAL-a297t-821722269be8469840036efee28e3f1e4fb2ea4c58007f4893cf7883333bfa213</originalsourceid><addsrcrecordid>eNpdkU9v1DAQxS0EokvhyoEDssSFSxb_S-Jwq7YtIC0Cse058jpj1ktib20naL8SnxKnW3pgLrY8v_c0nofQa0qWlBD6Ya8GtWSEVstKMP4ELWjJZcHLRj5FC0IaWdRCijP0IsY9yUV5_RydsbrkrKFygf6s7cF2eKMDgLPuJ7YOr3a273bed1i5Dl90voeowWnAxgd8CQl0st5hb_DXsU_WKJ18sKrHl8fYz34wWPURX035Nst-wMGHdO-2OcYEg0pW59fJwu97z7QDfLvB3wNM4JKdAG8gTFZDxDcq_sLXPmh4iZ4Z1Ud49XCeo9vrq5vV52L97dOX1cW6UKypUyEZrRljVbMFKapGCkJ4BQaASeCGgjBbBkroUhJSGyEbrk0tJc-1NYpRfo7en3wPwd-NEFM72Pz_vlcO_BhbKimTss77y-i7_9C9H4PL080UZ0SIUmRqeaJ08DEGMO0h2EGFY0tJO6fYzim2c4rtnGIWvH2wHbcDdI_4v9gy8OYEzLrHbilYJQj_C9N1oew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1813204454</pqid></control><display><type>article</type><title>Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Lozano, Paula ; Henrikson, Nora B ; Morrison, Caitlin C ; Dunn, John ; Nguyen, Matt ; Blasi, Paula R ; Whitlock, Evelyn P</creator><creatorcontrib>Lozano, Paula ; Henrikson, Nora B ; Morrison, Caitlin C ; Dunn, John ; Nguyen, Matt ; Blasi, Paula R ; Whitlock, Evelyn P</creatorcontrib><description>IMPORTANCE: Multifactorial dyslipidemia, characterized by elevated total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C), is associated with dyslipidemia and markers of atherosclerosis in young adulthood. Screening for dyslipidemia in childhood could delay or reduce cardiovascular events in adulthood. OBJECTIVE: To systematically review the evidence on benefits and harms of screening adolescents and children for multifactorial dyslipidemia for the US Preventive Services Task Force (USPSTF). DATA SOURCES: MEDLINE, Cochrane Central Register of Controlled Trials, and PubMed were searched for studies published between January 1, 2005, and June 2, 2015; studies included in a previous USPSTF evidence report and reference lists of relevant studies and ongoing trials were also searched. Surveillance was conducted through April 9, 2016. STUDY SELECTION: Fair- and good-quality studies in English with participants 0 to 20 years of age. DATA EXTRACTION AND SYNTHESIS: Two investigators independently reviewed abstracts and full-text articles and extracted data into evidence tables. Results were qualitatively summarized. MAIN OUTCOMES AND MEASURES: Outcomes included dyslipidemia (TC≥200 mg/dL or LDL-C≥130 mg/dL) and atherosclerosis in childhood; myocardial infarction and ischemic stroke in adulthood; diagnostic yield (number of confirmed cases per children screened); and harms of screening or treatment. Simulated diagnostic yield was calculated as initial screening yield × positive predictive value from a study with confirmatory testing. RESULTS: Screening of children for multifactorial dyslipidemia has not been evaluated in randomized clinical trials. Based on 1 observational study (n = 6500) and nationally representative prevalence estimates, the simulated diagnostic yield of screening for elevated TC varies between 4.8% and 12.3% (higher in obese children [12.3%] and at the ages when TC naturally peaks—7.2% at age 9-11 years and 7.2% at age 16-19 years). One good-quality randomized clinical trial (n = 663) found a modest effect of intensive dietary counseling for a low-fat, low-cholesterol diet on lipid levels at 1 year in children aged 8 to 10 years with mild to moderate dyslipidemia; mean between-group difference in TC change from baseline was −6.1 mg/dL (95% CI, −9.1 to −3.2 mg/dL; P &lt; .001). Between-group differences dissipated by year 5. The intervention did not adversely affect nutritional status, growth, or development over the 18-year study period. One observational study (n = 9245) found that TC concentration at age 12 to 39 years was not associated with death before age 55 years. CONCLUSIONS AND RELEVANCE: The diagnostic yield of lipid screening varies by age and body mass index. No direct evidence was identified for benefits or harms of childhood screening or treatment on outcomes in adulthood. Intensive dietary interventions may be safe, with modest short-term benefit of uncertain clinical significance.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.2016.6423</identifier><identifier>PMID: 27532918</identifier><identifier>CODEN: JAMAAP</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Adolescent ; Advisory Committees ; Age Distribution ; Age Factors ; Atherosclerosis - diagnosis ; Atherosclerosis - prevention &amp; control ; Biomarkers - blood ; Child ; Child, Preschool ; Childrens health ; Cholesterol - blood ; Cholesterol, LDL - blood ; Diet ; Dyslipidemias - diagnosis ; Dyslipidemias - epidemiology ; Dyslipidemias - etiology ; Dyslipidemias - therapy ; Female ; Humans ; Hypolipidemic Agents - therapeutic use ; Infant ; Infant, Newborn ; Life Style ; Lipids ; Male ; Mass Screening - adverse effects ; Mass Screening - methods ; Medical screening ; Myocardial Infarction - prevention &amp; control ; Preventive Health Services ; Stroke - prevention &amp; control ; Systematic review ; Task forces ; United States - epidemiology ; Young Adult</subject><ispartof>JAMA : the journal of the American Medical Association, 2016-08, Vol.316 (6), p.634-644</ispartof><rights>Copyright American Medical Association Aug 9, 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.2016.6423$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2016.6423$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,780,784,3340,27924,27925,76489,76492</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27532918$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lozano, Paula</creatorcontrib><creatorcontrib>Henrikson, Nora B</creatorcontrib><creatorcontrib>Morrison, Caitlin C</creatorcontrib><creatorcontrib>Dunn, John</creatorcontrib><creatorcontrib>Nguyen, Matt</creatorcontrib><creatorcontrib>Blasi, Paula R</creatorcontrib><creatorcontrib>Whitlock, Evelyn P</creatorcontrib><title>Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><description>IMPORTANCE: Multifactorial dyslipidemia, characterized by elevated total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C), is associated with dyslipidemia and markers of atherosclerosis in young adulthood. Screening for dyslipidemia in childhood could delay or reduce cardiovascular events in adulthood. OBJECTIVE: To systematically review the evidence on benefits and harms of screening adolescents and children for multifactorial dyslipidemia for the US Preventive Services Task Force (USPSTF). DATA SOURCES: MEDLINE, Cochrane Central Register of Controlled Trials, and PubMed were searched for studies published between January 1, 2005, and June 2, 2015; studies included in a previous USPSTF evidence report and reference lists of relevant studies and ongoing trials were also searched. Surveillance was conducted through April 9, 2016. STUDY SELECTION: Fair- and good-quality studies in English with participants 0 to 20 years of age. DATA EXTRACTION AND SYNTHESIS: Two investigators independently reviewed abstracts and full-text articles and extracted data into evidence tables. Results were qualitatively summarized. MAIN OUTCOMES AND MEASURES: Outcomes included dyslipidemia (TC≥200 mg/dL or LDL-C≥130 mg/dL) and atherosclerosis in childhood; myocardial infarction and ischemic stroke in adulthood; diagnostic yield (number of confirmed cases per children screened); and harms of screening or treatment. Simulated diagnostic yield was calculated as initial screening yield × positive predictive value from a study with confirmatory testing. RESULTS: Screening of children for multifactorial dyslipidemia has not been evaluated in randomized clinical trials. Based on 1 observational study (n = 6500) and nationally representative prevalence estimates, the simulated diagnostic yield of screening for elevated TC varies between 4.8% and 12.3% (higher in obese children [12.3%] and at the ages when TC naturally peaks—7.2% at age 9-11 years and 7.2% at age 16-19 years). One good-quality randomized clinical trial (n = 663) found a modest effect of intensive dietary counseling for a low-fat, low-cholesterol diet on lipid levels at 1 year in children aged 8 to 10 years with mild to moderate dyslipidemia; mean between-group difference in TC change from baseline was −6.1 mg/dL (95% CI, −9.1 to −3.2 mg/dL; P &lt; .001). Between-group differences dissipated by year 5. The intervention did not adversely affect nutritional status, growth, or development over the 18-year study period. One observational study (n = 9245) found that TC concentration at age 12 to 39 years was not associated with death before age 55 years. CONCLUSIONS AND RELEVANCE: The diagnostic yield of lipid screening varies by age and body mass index. No direct evidence was identified for benefits or harms of childhood screening or treatment on outcomes in adulthood. Intensive dietary interventions may be safe, with modest short-term benefit of uncertain clinical significance.</description><subject>Adolescent</subject><subject>Advisory Committees</subject><subject>Age Distribution</subject><subject>Age Factors</subject><subject>Atherosclerosis - diagnosis</subject><subject>Atherosclerosis - prevention &amp; control</subject><subject>Biomarkers - blood</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Childrens health</subject><subject>Cholesterol - blood</subject><subject>Cholesterol, LDL - blood</subject><subject>Diet</subject><subject>Dyslipidemias - diagnosis</subject><subject>Dyslipidemias - epidemiology</subject><subject>Dyslipidemias - etiology</subject><subject>Dyslipidemias - therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Hypolipidemic Agents - therapeutic use</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Life Style</subject><subject>Lipids</subject><subject>Male</subject><subject>Mass Screening - adverse effects</subject><subject>Mass Screening - methods</subject><subject>Medical screening</subject><subject>Myocardial Infarction - prevention &amp; control</subject><subject>Preventive Health Services</subject><subject>Stroke - prevention &amp; control</subject><subject>Systematic review</subject><subject>Task forces</subject><subject>United States - epidemiology</subject><subject>Young Adult</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU9v1DAQxS0EokvhyoEDssSFSxb_S-Jwq7YtIC0Cse058jpj1ktib20naL8SnxKnW3pgLrY8v_c0nofQa0qWlBD6Ya8GtWSEVstKMP4ELWjJZcHLRj5FC0IaWdRCijP0IsY9yUV5_RydsbrkrKFygf6s7cF2eKMDgLPuJ7YOr3a273bed1i5Dl90voeowWnAxgd8CQl0st5hb_DXsU_WKJ18sKrHl8fYz34wWPURX035Nst-wMGHdO-2OcYEg0pW59fJwu97z7QDfLvB3wNM4JKdAG8gTFZDxDcq_sLXPmh4iZ4Z1Ud49XCeo9vrq5vV52L97dOX1cW6UKypUyEZrRljVbMFKapGCkJ4BQaASeCGgjBbBkroUhJSGyEbrk0tJc-1NYpRfo7en3wPwd-NEFM72Pz_vlcO_BhbKimTss77y-i7_9C9H4PL080UZ0SIUmRqeaJ08DEGMO0h2EGFY0tJO6fYzim2c4rtnGIWvH2wHbcDdI_4v9gy8OYEzLrHbilYJQj_C9N1oew</recordid><startdate>20160809</startdate><enddate>20160809</enddate><creator>Lozano, Paula</creator><creator>Henrikson, Nora B</creator><creator>Morrison, Caitlin C</creator><creator>Dunn, John</creator><creator>Nguyen, Matt</creator><creator>Blasi, Paula R</creator><creator>Whitlock, Evelyn P</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20160809</creationdate><title>Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force</title><author>Lozano, Paula ; Henrikson, Nora B ; Morrison, Caitlin C ; Dunn, John ; Nguyen, Matt ; Blasi, Paula R ; Whitlock, Evelyn P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a297t-821722269be8469840036efee28e3f1e4fb2ea4c58007f4893cf7883333bfa213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Advisory Committees</topic><topic>Age Distribution</topic><topic>Age Factors</topic><topic>Atherosclerosis - diagnosis</topic><topic>Atherosclerosis - prevention &amp; control</topic><topic>Biomarkers - blood</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Childrens health</topic><topic>Cholesterol - blood</topic><topic>Cholesterol, LDL - blood</topic><topic>Diet</topic><topic>Dyslipidemias - diagnosis</topic><topic>Dyslipidemias - epidemiology</topic><topic>Dyslipidemias - etiology</topic><topic>Dyslipidemias - therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Hypolipidemic Agents - therapeutic use</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Life Style</topic><topic>Lipids</topic><topic>Male</topic><topic>Mass Screening - adverse effects</topic><topic>Mass Screening - methods</topic><topic>Medical screening</topic><topic>Myocardial Infarction - prevention &amp; control</topic><topic>Preventive Health Services</topic><topic>Stroke - prevention &amp; control</topic><topic>Systematic review</topic><topic>Task forces</topic><topic>United States - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lozano, Paula</creatorcontrib><creatorcontrib>Henrikson, Nora B</creatorcontrib><creatorcontrib>Morrison, Caitlin C</creatorcontrib><creatorcontrib>Dunn, John</creatorcontrib><creatorcontrib>Nguyen, Matt</creatorcontrib><creatorcontrib>Blasi, Paula R</creatorcontrib><creatorcontrib>Whitlock, Evelyn P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lozano, Paula</au><au>Henrikson, Nora B</au><au>Morrison, Caitlin C</au><au>Dunn, John</au><au>Nguyen, Matt</au><au>Blasi, Paula R</au><au>Whitlock, Evelyn P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2016-08-09</date><risdate>2016</risdate><volume>316</volume><issue>6</issue><spage>634</spage><epage>644</epage><pages>634-644</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><coden>JAMAAP</coden><abstract>IMPORTANCE: Multifactorial dyslipidemia, characterized by elevated total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C), is associated with dyslipidemia and markers of atherosclerosis in young adulthood. Screening for dyslipidemia in childhood could delay or reduce cardiovascular events in adulthood. OBJECTIVE: To systematically review the evidence on benefits and harms of screening adolescents and children for multifactorial dyslipidemia for the US Preventive Services Task Force (USPSTF). DATA SOURCES: MEDLINE, Cochrane Central Register of Controlled Trials, and PubMed were searched for studies published between January 1, 2005, and June 2, 2015; studies included in a previous USPSTF evidence report and reference lists of relevant studies and ongoing trials were also searched. Surveillance was conducted through April 9, 2016. STUDY SELECTION: Fair- and good-quality studies in English with participants 0 to 20 years of age. DATA EXTRACTION AND SYNTHESIS: Two investigators independently reviewed abstracts and full-text articles and extracted data into evidence tables. Results were qualitatively summarized. MAIN OUTCOMES AND MEASURES: Outcomes included dyslipidemia (TC≥200 mg/dL or LDL-C≥130 mg/dL) and atherosclerosis in childhood; myocardial infarction and ischemic stroke in adulthood; diagnostic yield (number of confirmed cases per children screened); and harms of screening or treatment. Simulated diagnostic yield was calculated as initial screening yield × positive predictive value from a study with confirmatory testing. RESULTS: Screening of children for multifactorial dyslipidemia has not been evaluated in randomized clinical trials. Based on 1 observational study (n = 6500) and nationally representative prevalence estimates, the simulated diagnostic yield of screening for elevated TC varies between 4.8% and 12.3% (higher in obese children [12.3%] and at the ages when TC naturally peaks—7.2% at age 9-11 years and 7.2% at age 16-19 years). One good-quality randomized clinical trial (n = 663) found a modest effect of intensive dietary counseling for a low-fat, low-cholesterol diet on lipid levels at 1 year in children aged 8 to 10 years with mild to moderate dyslipidemia; mean between-group difference in TC change from baseline was −6.1 mg/dL (95% CI, −9.1 to −3.2 mg/dL; P &lt; .001). Between-group differences dissipated by year 5. The intervention did not adversely affect nutritional status, growth, or development over the 18-year study period. One observational study (n = 9245) found that TC concentration at age 12 to 39 years was not associated with death before age 55 years. CONCLUSIONS AND RELEVANCE: The diagnostic yield of lipid screening varies by age and body mass index. No direct evidence was identified for benefits or harms of childhood screening or treatment on outcomes in adulthood. Intensive dietary interventions may be safe, with modest short-term benefit of uncertain clinical significance.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>27532918</pmid><doi>10.1001/jama.2016.6423</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0098-7484
ispartof JAMA : the journal of the American Medical Association, 2016-08, Vol.316 (6), p.634-644
issn 0098-7484
1538-3598
language eng
recordid cdi_proquest_miscellaneous_1812887291
source MEDLINE; American Medical Association Journals
subjects Adolescent
Advisory Committees
Age Distribution
Age Factors
Atherosclerosis - diagnosis
Atherosclerosis - prevention & control
Biomarkers - blood
Child
Child, Preschool
Childrens health
Cholesterol - blood
Cholesterol, LDL - blood
Diet
Dyslipidemias - diagnosis
Dyslipidemias - epidemiology
Dyslipidemias - etiology
Dyslipidemias - therapy
Female
Humans
Hypolipidemic Agents - therapeutic use
Infant
Infant, Newborn
Life Style
Lipids
Male
Mass Screening - adverse effects
Mass Screening - methods
Medical screening
Myocardial Infarction - prevention & control
Preventive Health Services
Stroke - prevention & control
Systematic review
Task forces
United States - epidemiology
Young Adult
title Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T07%3A19%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lipid%20Screening%20in%20Childhood%20and%20Adolescence%20for%20Detection%20of%20Multifactorial%20Dyslipidemia:%20Evidence%20Report%20and%20Systematic%20Review%20for%20the%20US%20Preventive%20Services%20Task%20Force&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Lozano,%20Paula&rft.date=2016-08-09&rft.volume=316&rft.issue=6&rft.spage=634&rft.epage=644&rft.pages=634-644&rft.issn=0098-7484&rft.eissn=1538-3598&rft.coden=JAMAAP&rft_id=info:doi/10.1001/jama.2016.6423&rft_dat=%3Cproquest_cross%3E4155808381%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1813204454&rft_id=info:pmid/27532918&rft_ama_id=2542640&rfr_iscdi=true